Doll - Google Patents
Method for enhanced transmembrane transport of exogenous moleculDoll
- Document ID
- 8299320664734524603
- Author
- Doll J
External Links
Snippet
A method is provided for enhancing transmembrane transport of exogenous molecules. The method comprises contacting a membrane of a living cell with a complex formed between said molecules and ligands selected from biotin, biotin analogs and other biotin receptor …
- 238000000034 method 0 title abstract description 17
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1062—Isolating an individual clone by screening libraries mRNA-Display, e.g. polypeptide and encoding template are connected covalently
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using micro-encapsulation, e.g. using amphiphile liposome vesicle
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bhattacharya et al. | A minimal biochemical route towards de novo formation of synthetic phospholipid membranes | |
| Miao et al. | Bispecific aptamer chimeras enable targeted protein degradation on cell membranes | |
| Wang et al. | Lipid conjugates enhance endosomal release of antisense oligonucleotides into cells | |
| Li et al. | Cell-membrane-anchored DNA nanoplatform for programming cellular interactions | |
| Reid et al. | Diversity and selectivity in mRNA translation on the endoplasmic reticulum | |
| WO2020047010A4 (en) | Increasing spatial array resolution | |
| Krinsky et al. | Synthetic cells synthesize therapeutic proteins inside tumors | |
| van der Laan et al. | Reconstitution of Sec‐dependent membrane protein insertion: nascent FtsQ interacts with YidC in a SecYEG‐dependent manner | |
| Mokranjac et al. | Thirty years of protein translocation into mitochondria: unexpectedly complex and still puzzling | |
| Park et al. | Fluorinated and hemifluorinated surfactants as alternatives to detergents for membrane protein cell-free synthesis | |
| JP4250523B2 (en) | Microreactor, analysis system, analysis method, reaction system, reaction method, separation system, separation method | |
| Rakestraw et al. | Secretion-and-capture cell-surface display for selection of target-binding proteins | |
| Millard et al. | Riding the DUBway: regulation of protein trafficking by deubiquitylating enzymes | |
| Zhao et al. | Mimicking cellular metabolism in artificial cells: universal molecule transport across the membrane through vesicle fusion | |
| Rondanino et al. | Sugar-dependent nuclear import of glycosylated proteins in living cells | |
| Wu et al. | Nucleic acid-based cell surface engineering strategies and their applications | |
| Mukhopadhyay et al. | A co-translational model to explain the in vivo import of proteins into HeLa cell mitochondria | |
| CN114410636B (en) | Improved AS1411 aptamer and EVs coupled by using same | |
| Heili et al. | Controlled exchange of protein and nucleic acid signals from and between synthetic minimal cells | |
| Chen et al. | Identification of the Binding Site between Aptamer sgc8c and PTK7 | |
| Schreiber et al. | Affinity of TatCd for TatAd elucidates its receptor function in the Bacillus subtilis twin arginine translocation (Tat) translocase system | |
| Ngo et al. | Extracellular Vesicles and Cellular Homeostasis | |
| Steinkühler et al. | Improving cell-free expression of model membrane proteins by tuning ribosome cotranslational membrane association and nascent chain aggregation | |
| Giancola et al. | Evaluation of the cytosolic uptake of HaloTag using a pH-sensitive dye | |
| Doll | Method for enhanced transmembrane transport of exogenous molecul |